Neme$y$ writes: The BBC reports that "An international team of researchers, led by experts from the US, will oversee the trial of the vaccine, created by the drug company Merck.". According to CBC News : The study is a "test of concept" trial that will help researchers determine if the vaccine prevents HIV infections, results in lower HIV levels in those who become infected after vaccination or both. "South Africa is an excellent location for this trial due to the high levels of infection coupled with the good clinical infrastructure, including internationally recognized immunology laboratories, a well-established national vaccine initiative and experience in running clinical trials," said James Kublin, M.D., M.P.H., one of study's lead investigators, along with Glenda Gray, MBBCH, FCPaeds (SA), of the Perinatal HIV Research Unit, University of the Witwatersrand, based at the Chris Hani Baragwanath Hospital in Soweto. A more detailed explanation here.
DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Also, Slashdot's Facebook page has a chat bot now. Message it for stories and more. Check out the new SourceForge HTML5 Internet speed test! ×